Status | Study |
Recruiting |
Study Name: Registry of Older Patients With Cancer Condition: Chronic Myeloproliferative Disorders Cognitive/Functional Effects Date: 2010-06-03 |
Recruiting |
Study Name: Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer Condition: Chronic Myeloproliferative Disorders Leukemia Lymphoma Date: 2010-06-03 Interventions: Other: biologic sample preservation procedure |
Terminated |
Study Name: Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation Condition: Chronic Myeloproliferative Disorders Graft Versus Host Disease Date: 2010-05-03 Interventions: Biological: anti-thymocyte globulin |
Withdrawn |
Study Name: Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Condition: Chronic Myeloproliferative Disorders Infection Leukemia Date: 2010-04-09 Interventions: Drug: Edetate Calcium Disodium |
Active, not recruiting |
Study Name: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Undifferentiated Leukemia Date: 2010-01-20 Interventions: Procedure: massage therapy Und |
Completed |
Study Name: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2009-04-29 Interventions: Drug: sunitinib malate Given P |
Active, not recruiting |
Study Name: Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2009-03-04 Interventions: Drug: fludarabine phosphate Gi |
Completed |
Study Name: Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2008-11-26 Interventions: Other: internet-based intervention |
Completed |
Study Name: Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2008-11-20 Interventions: Drug: ondansetron Given IV |
Withdrawn |
Study Name: Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer Condition: Myeloproliferative Disorders Leukemia Lymphoma Date: 2007-07-10 Interventions: Drug: aprepitant 125 mg orally |